X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (34) 34
oncology (32) 32
humans (30) 30
breast cancer (25) 25
female (24) 24
middle aged (18) 18
adult (15) 15
cancer (15) 15
aged (13) 13
breast neoplasms - drug therapy (12) 12
article (11) 11
metastasis (10) 10
antineoplastic agents - therapeutic use (9) 9
breast neoplasms - pathology (9) 9
chemotherapy (9) 9
tumors (8) 8
aged, 80 and over (7) 7
breast neoplasms - diagnostic imaging (7) 7
epidermal growth factor (7) 7
trastuzumab (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
medicine & public health (6) 6
solid tumors (6) 6
biomarkers (5) 5
breast (5) 5
breast-cancer (5) 5
clinical trials (5) 5
erbb-2 protein (5) 5
fluorodeoxyglucose f18 (5) 5
hsp90 (5) 5
hsp90 heat-shock proteins - antagonists & inhibitors (5) 5
male (5) 5
metastases (5) 5
neoplasms - drug therapy (5) 5
patients (5) 5
survival (5) 5
tanespimycin 17-aag (5) 5
therapy (5) 5
treatment outcome (5) 5
abridged index medicus (4) 4
antineoplastic agents - pharmacology (4) 4
breast neoplasms - genetics (4) 4
care and treatment (4) 4
hematology, oncology and palliative medicine (4) 4
her2 (4) 4
hsp90 heat-shock proteins - metabolism (4) 4
mutation (4) 4
pet (4) 4
pet/ct (4) 4
pharmacokinetics (4) 4
positron-emission tomography - methods (4) 4
prognosis (4) 4
radiopharmaceuticals (4) 4
receptor, erbb-2 - genetics (4) 4
research (4) 4
systemic therapy (4) 4
antineoplastic combined chemotherapy protocols - pharmacology (3) 3
antitumor-activity (3) 3
avidity (3) 3
bone metastases (3) 3
breast neoplasms - diagnosis (3) 3
breast neoplasms - metabolism (3) 3
breast neoplasms - mortality (3) 3
cell biology (3) 3
clinical trials as topic (3) 3
diarrhea (3) 3
disease progression (3) 3
disease-free survival (3) 3
dosage and administration (3) 3
dose-response relationship, drug (3) 3
dosimetry (3) 3
expression (3) 3
growth (3) 3
heat shock proteins (3) 3
inhibitor (3) 3
kaplan-meier estimate (3) 3
kinases (3) 3
liver neoplasms - diagnostic imaging (3) 3
liver neoplasms - secondary (3) 3
metastatic breast cancer (3) 3
metastatic breast-cancer (3) 3
obstetrics and gynecology (3) 3
pertuzumab (3) 3
pharmacology (3) 3
phase-ii (3) 3
positron emission tomography (3) 3
postmenopausal women (3) 3
potent antitumor-activity (3) 3
radiology, nuclear medicine & medical imaging (3) 3
receptor, erbb-2 - metabolism (3) 3
receptors, estrogen - metabolism (3) 3
receptors, progesterone - metabolism (3) 3
skin and connective tissue diseases (3) 3
tomography (3) 3
toxicity (3) 3
trial (3) 3
1-phosphatidylinositol 3-kinase (2) 2
17-allylamino (2) 2
17-allylamino-17-demethoxygeldanamycin (2) 2
89zr-pertuzumab (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 01/2017, Volume 35, Issue 2, pp. 127 - 130
Journal Article
Clinical advances in hematology & oncology : H&O, ISSN 1543-0790, 02/2019, Volume 17, Issue 2, pp. 105 - 108
Journal Article
Journal Article
Nature, ISSN 0028-0836, 02/2018, Volume 554, Issue 7691, pp. 189 - 194
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2018, Volume 24, Issue 15, pp. 3510 - 3518
Purpose: AZD9496 is an oral nonsteroidal, small-molecule inhibitor of estrogen receptor alpha (ER alpha) and a potent and selective antagonist and degrader of... 
ENDOCRINE RESISTANCE | TRIALS | FULVESTRANT 500 MG | THERAPY | ONCOLOGY | TAMOXIFEN | ESR1 MUTATIONS | MECHANISMS | POSTMENOPAUSAL WOMEN | INHIBITOR | Nausea - chemically induced | Receptor, ErbB-2 - genetics | Cinnamates - administration & dosage | Humans | Middle Aged | Selective Estrogen Receptor Modulators - adverse effects | Protein Kinase Inhibitors - adverse effects | Indoles - administration & dosage | Drug-Related Side Effects and Adverse Reactions - pathology | Dose-Response Relationship, Drug | Aged, 80 and over | Adult | Female | Selective Estrogen Receptor Modulators - administration & dosage | Breast Neoplasms - drug therapy | Protein Kinase Inhibitors - administration & dosage | Maximum Tolerated Dose | Breast Neoplasms - genetics | Estrogen Receptor alpha - genetics | Indoles - adverse effects | Breast Neoplasms - pathology | Breast Neoplasms - blood | Cinnamates - adverse effects | Aged | Biomarkers, Tumor - genetics | Nausea - pathology | Drug-Related Side Effects and Adverse Reactions - classification | Slopes | Tumor markers | Toxicity | Liver | Estrogens | Estrogen receptors | Diarrhea | Fatigue | Mass spectroscopy | Nausea | Breast cancer | Pharmacology | Patients | ErbB-2 protein | Anticancer properties | Safety engineering | Breast | Antitumor activity | Safety | Solid tumors | Mass spectrometry | Cancer | Tumors
Journal Article
Cancer Discovery, ISSN 2159-8274, 03/2019, Volume 9, Issue 3, pp. 323 - 325
Standard treatment for estrogen receptor-positive metastatic breast cancer involves antiestrogen therapy used alone or in combination with inhibitors of CDK4/6... 
ONCOLOGY | BCL2 | Receptors, Estrogen | Sulfonamides | Humans | Bridged Bicyclo Compounds, Heterocyclic | Proto-Oncogene Proteins c-bcl-2 | Breast Neoplasms | Tamoxifen | Apoptosis
Journal Article
Current Breast Cancer Reports, ISSN 1943-4588, 12/2013, Volume 5, Issue 4, pp. 321 - 330
The neoadjuvant strategy, initially developed to render primary inoperable tumors operable, is now increasingly being utilized for patients with... 
Medicine & Public Health | Clinical trials | Oncology | Internal Medicine | HER2 positive | Neoadjuvant | Breast cancer | Dual blockade | Surgical Oncology | pCR | Medical colleges | Epidermal growth factor
Journal Article
Current Breast Cancer Reports, ISSN 1943-4588, 06/2017, Volume 9, Issue 2, pp. 61 - 69
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s12609-017-0239-6 Byline:... 
Commentary | Breast cancer | HER2 | Human epidermal growth factor receptor 2 | HER3 | Epidermal growth factor | Resveratrol
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 2/2018, Volume 168, Issue 1, pp. 57 - 67
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 02/2016, Volume 57, pp. 53S - 53S
The success of breast cancer therapy is ultimately defined by clinical endpoints such as survival. It is valuable to have biomarkers that can predict the most... 
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 02/2016, Volume 57, p. 53S
  The success of breast cancer therapy is ultimately defined by clinical endpoints such as survival. It is valuable to have biomarkers that can predict the... 
Medical treatment | Biomarkers | Clinical trials | Breast cancer
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.